title: Treatment of acute myelogenous leukemia.
authors.forename: S
authors.initials: S
authors.lastname: Slater
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: M
authors.initials: M
authors.lastname: Murphy
authors.forename: J
authors.initials: J
authors.lastname: Amess
authors.forename: M
authors.initials: M
authors.lastname: Carter
authors.forename: T A
authors.initials: TA
authors.lastname: Lister
authors.forename: S
authors.initials: S
authors.lastname: Johnson
authors.forename: M
authors.initials: M
authors.lastname: Ewings
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D016179:Granulocyte Colony-Stimulating Factor